Table 3.
Base rate | Sensitivity | Specificity | PPV | NPV | Efficiency | Kappa | ||
---|---|---|---|---|---|---|---|---|
14 | High P-SDQ score | 0.17 | 0.51 | 0.94 | 0.74 | 0.85 | 0.83 | 0.50 |
15 | High Y-SDQ score | 0.05 | 0.18 | 0.99 | 0.83 | 0.79 | 0.79 | 0.23 |
16 | High P-SDQ symptom + impact | 0.24 | 0.69 | 0.91 | 0.71 | 0.90 | 0.86 | 0.60 |
17 | High Y-SDQ symptom + impact | 0.06 | 0.20 | 0.98 | 0.81 | 0.79 | 0.79 | 0.25 |
18 | High PY-SDQ symptom + impact | 0.23 | 0.72 | 0.93 | 0.78 | 0.91 | 0.88 | 0.67 |
19 | High P-DAWBA band | 0.14 | 0.52 | 0.98 | 0.88 | 0.86 | 0.86 | 0.57 |
20 | High Y-DAWBA band | 0.09 | 0.36 | 0.99 | 0.94 | 0.83 | 0.84 | 0.45 |
21 | High PY-DAWBA band | 0.18 | 0.64 | 0.97 | 0.88 | 0.89 | 0.89 | 0.67 |
SDQ Strengths and Difficulties Questionnaire, DAWBA Development and Well-Being Assessment, all kappas significant at p < 0.001; PPV positive predicted value, NPV negative predicted value